Larger, More Modern Facility Enhances Company’s Capabilities
Research Triangle Park, North Carolina, October 11, 2016 – Marken announced the opening of a new depot and logistics operation in Argentina, which will replace the current location. The new location is larger, more modern and will expand its capabilities in the region. An opening event is scheduled on November 15-16, in Buenos Aires.
The new depot facility will be co-located with a new logistics office in Buenos Aires. The depot will significantly increase Marken’s drug storage and distribution capacity to serve its clients in the region. The depot its logistics operations are GMP and GDP-compliant* which are aligned with Marken’s own Gold Book compliance standards. The depot will also have a full range of temperature storage capacities and validated capabilities for late stage customization of drug product.
The new facility is located in the Tortuguitas Province, approximately 40 kilometers northwest of Buenos Aires. It is adjacent to major highways, which allows easy access to international and domestic airports as well as local clinical investigator sites.
State of the art IT technology will enable the new office and depot to operate within Marken’s worldwide network of 43 locations. Drug shipments will be monitored by Sentry™, a real time GPS tracking system which is connected to the Maestro™ operating system. The depot’s inventory is tracked in Solo™, a GMP-compliant, cloud-based system which provides continuous access to Marken’s clients.
Argentina is the fourth-largest pharmaceutical market in the world behind the US, China, and Japan. With a relatively low-cost base and high-quality professionals in the biotechnology sector, Argentina is home to over 130 biotechnology companies. Argentina is considered a favorable source for cost-effective clinical trials within Latin America, and was one of the first Latin American countries to implement the recommendations of the WHO Good Manufacturing Practices and Control standards which endorses compliance to an international set of quality standards for pharmaceutical production.
Wes Wheeler, Marken’s CEO, commented, “We are proud that after just three years of establishing our first depot in Argentina, we are now in need of larger space and greater capabilities in order to meet the growing demand of our clients in Argentina and Latin America. Having a larger presence in Buenos Aires will ensure that Marken has the expanded capacity to grow with our clients and provide full service, global clinical supply chain solutions.”
The depot is in the final phases of commissioning and is planned to officially open during the 3rd week of November. Invitations for the grand opening event will be announced shortly.
*Good Manufacturing Practices and Good Distribution Practices.
Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient services and biological sample shipments, and offers a state of the art GMP-compliant depot network and logistic hubs in 43 locations worldwide. Marken’s 630 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 150 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.
CONTACT: Christine Noble, email@example.com, +1 919 474 6890, www.marken.comBack to Index